First Aid Direct Cold-EEZE Cold Remedy NDC 42961-105

NDC codes

FDA NDC Directory

Product NDC (as listed)42961-105Labeler and product segments. Claims need a package NDC.

Product NDC at billing width42961-0105Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
42961-105-02	42961010502	20 PACKET in 1 PACKAGE (42961-105-02) / 1 LOZENGE in 1 PACKET (42961-105-01)Marketed from Jul 20, 2023

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): First Aid Direct Cold-EEZE Cold Remedy
Generic name (nonproprietary): zinc gluconate
Active ingredients: Zinc gluconate — 2 [hp_X]/1
Dosage form: Lozenge
Route: Oral
Labeler: Cintas Corporation
Product type: Over-the-counter drug
Marketing category: Unapproved homeopathic
Marketing start: Jul 20, 2023
Listing expires: Dec 31, 2026
Other FDA classes: Decreased Copper Ion Absorption (Physiologic effect)
Identifiers: Product ID 42961-105_46d09884-a4a0-4e88-b9f5-41b10ea8d79dSPL ID 46d09884-a4a0-4e88-b9f5-41b10ea8d79dSPL set ID a6c5906d-8f04-42f7-885f-e7490ec6b5bcUNII U6WSN5SQ1Z
Pharmacologic class: Copper Absorption Inhibitor

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N442961010502 followed by a unit qualifier and the quantity

Package 42961-0105-02. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Sep 23, 2025.

Indications (excerpt from the label)

Uses reduces the duration of the common cold reduces the severity of cold symptoms: cough, sore throat, nasal congestion, post nasal drip and/or hoarseness

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)